Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Phase IIa Laquinimod trail results show positive data for Chron's
Yahoo/Fly on the Wall
Monday, October 22, 2012 - 11:41am
tags:
Chron's Disease, laquinimod, Teva
Orexigen receives dispute response from FDA
The Fly on the Wall
Monday, October 22, 2012 - 11:37am
tags:
FDA, Orexigen, Contrave
Eli Lilly's Upcoming Earnings: What You Need To Know
Motley Fool
Monday, October 22, 2012 - 11:37am
tags:
earnings, Eli Lilly
Abbott announces results from analysis of extension of Humira studies
The Fly on the Wall
Monday, October 22, 2012 - 11:32am
tags:
Humira, Abbott Labs, ulcerative colitis
Bristol-Myers Squibb Earnings Up Next
Motley Fool
Monday, October 22, 2012 - 11:30am
tags:
Bristol-Myers Squibb, earnings
[video]3 Big Events for 1 Big Pharma
Motley Fool
Monday, October 22, 2012 - 11:24am
tags:
Abbott Labs
Lilly Diabetes Medicine Meets Goal in Three Studies
Bloomberg
Monday, October 22, 2012 - 11:23am
tags:
diabetes, Eli Lilly, dulaglutide
Pfizer to Pay as Much as $700 Million for ADHD Drug
Bloomberg
Monday, October 22, 2012 - 11:02am
tags:
ADHD, Pfizer, NextWave Pharmaceuticals, Quillivant XR
United Therapeutics Could Lose The Battle For PAH Therapies
TheStreet.com
Monday, October 22, 2012 - 10:57am
tags:
United Therapeutics, PAH, Remodulin, Tyvaso, Adcirca
Abbott Laboratories - Company Spin-Off Could Unlock Value For Shareholders
Seeking Alpha
Monday, October 22, 2012 - 10:52am
tags:
Abbott Labs, AbbVie
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Monday, October 22, 2012 - 10:52am
tags:
Regeneron, Eyela, Gilead, GS-7977, Merck, Eli Lilly, Singulair, Molina Healthcare
Wall Street Loves Amarin. Should You?
Motley Fool
Monday, October 22, 2012 - 10:31am
tags:
Amarin, Vascepa
Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia
Yahoo
Monday, October 22, 2012 - 10:19am
tags:
Alnylam, Genzyme, RNAi, Asia
Paladin Announces Agreement for Novel OTC Product to Treat Cold Sores
Melodika
Sunday, October 21, 2012 - 11:12am
tags:
Paladin, Dynamiclear, cold sores
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Zolmax
Sunday, October 21, 2012 - 11:10am
tags:
Ohr Pharmaceutical, macular degeneration, Squalamine Eye Drops, OHR/AVR 118, Cancer Cachexia
China Biotech In Review: Pharmaron Announces Multi-Year Drug Discovery Partnership With AstraZeneca
Seeking Alpha
Sunday, October 21, 2012 - 11:07am
tags:
Pharmaron, LifeTech Scientific, Fosun Pharmaceutical, Shenzhen Hepalink Pharmaceutical, ProMetic Life Sciences, TNI BioTech, AstraZeneca, WuXi AppTech, Complete Genomics, Illumina
What You Need to Know About Biogen's Blockbuster
Motley Fool
Sunday, October 21, 2012 - 10:58am
tags:
Biogen Idec
4 European Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sunday, October 21, 2012 - 10:53am
tags:
AstraZeneca, GSK, Novartis, Sanofi
Amgen Earnings Sneak Peek
Wall Street Cheat Street
Sunday, October 21, 2012 - 10:52am
tags:
Amgen, earnings
The Dangers of Chasing Performance in Biotech (video)
Motley Fool
Sunday, October 21, 2012 - 10:51am
tags:
Sarepta Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.